RYAMRA Trademark Information

Trademark by Idorsia Pharmaceuticals Ltd

Pharmaceutical preparations for humans for the prevention and treatment of cardiovascular diseases, hypertension, vasospasm associated with aneurysmal subarachnoid hemorrhage, kidney diseases, pulmonary diseases, fibrotic diseases, cystic fibrosis, inflammatory diseases, allergic diseases, auto-immune diseases and disorders, neurodegenerative diseases, neurological disorders, diseases and disorders of the central nervous system, dementia, slee...

Classification Information

Use in Commerce Trademark - Applicant has provided proof of use of this mark in commerce to USPTO.

Primary Class: Class Details:
Class (005)
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
First Use Anywhere:: Not provided
First Use In Commerce: Not provided
General Information
Word mark: RYAMRA
Status/Status Date:
REGISTERED
11/3/2020
Serial Number: 79274312
Filing Date: 11/6/2019
Registration Number: 6187268
Registration Date: 11/3/2020
Goods and Services: Pharmaceutical preparations for humans for the prevention and treatment of cardiovascular diseases, hypertension, vasospasm associated with aneurysmal subarachnoid hemorrhage, kidney diseases, pulmonary diseases, fibrotic diseases, cystic fibrosis, inflammatory diseases, allergic diseases, auto-immune diseases and disorders, neurodegenerative diseases, neurological disorders, diseases and disorders of the central nervous system, dementia, sleep disorders, anxiety disorders, addictions, eating disorders, epilepsy, metabolic disorders, diabetes, glycolipid storage disorders, Fabry disease and symptoms and sequelae of Fabry disease, infectious diseases, and cancer
Mark Description: NOT AVAILABLE
Type Of Mark: TradeMark
Published For Opposition Date: 8/18/2020
Last Applicant/Owner:
Idorsia Pharmaceuticals Ltd
Mark Drawing Code: Standard Character Mark
Design Search:
(NO DATA)
Register Type: Principal
Disclaimer: (NOT AVAILABLE)
Correspondent:
Blue Filament Law PLLC
700 E. Maple Rd.
Suite 450
Birmingham, MI 48009
Current Status:
REGISTERED
11/3/2020
Correspondent Search:
Mary Margaret L. O'Donnell is a correspondent of RYAMRA trademark.
Current Overall Rating:
RatingRatingRatingRatingRating

(0 review)

As seen on